buyWeak
Bill Maher bought $10k of VFL
director at Delaware Investments National Municipal Income Fund. 1,000 shares at an average of $10.19, traded Dec 28, 2023, filed Jan 2, 2024.
Conviction score
23Value
$10k
1,000 shares
Holdings after
1,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$10k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-000363, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 28, 2023 | POpen-market purchase Common Stockindirect: By Self as Owner of Maher/Goldhammer Revocable Trust | +1,000 | $10.19 | $10k | 1,000 | Jan 2, 2024 |
Related signals
Other insiders at Delaware Investments National Municipal Income Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | VFLbuy Delaware Investments National Municipal Income Fund | Todd Reit director | $2,410 250 shares | +25% | |
| 25Weak | VFLbuy Delaware Investments National Municipal Income Fund | Nancy Yao director | $4,980 500 shares | +50% | |
| 23Weak | VFLbuy Delaware Investments National Municipal Income Fund | Nancy Yao director | $11k 1,000 shares | - | |
| 25Weak | VFLbuy Delaware Investments National Municipal Income Fund | Bill Maher director | $22k 2,000 shares | +194% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.